Investor Relations
- Top
- Investor Relations
IR News
-
2026.01.20Release(リリース)Marketing Approval for new specification of Ustekinumab Biosimilar ― USTEKINUMAB BS 90㎎ Syringe for S.C. Injection「F」―
-
2025.11.27Other(その他)Notice of the 61th Ordinary General Meeting of Shareholders
-
2025.11.21Release(リリース)Notice of Additional Approval for the indication of NextstellisTM by OLIC (Thailand) Limited
